156 results
Page 4 of 8
8-K
EX-10.3
yv4s1ifz
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-99.1
04eej4 4m
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
kc2oo1
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
opdatz
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
1680i78ssj4fkvesa
24 Jun 20
Business combination disclosure
5:11pm
8-K
4z9sztpsw4pqig8q61e
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.3
uapt42d2jv pr
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-2.1
wct3c
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
8su9ultu
24 Jun 20
Business combination disclosure
4:03pm
425
7ccl2bmdd2d0ti3r
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.4
22qwc6u5j18izdp66yb
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
xd3zif18j7vdf1z
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.2
fjl6zmv
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
15huw75
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm